Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

National News

$2 Million Grant for VaxGen

June 12, 2003

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

VaxGen Inc. will receive as much as $2 million in grant money from the National Institute of Allergy and Infectious Diseases to mine data from its disappointing AIDS vaccine trial. The study will seek clues that might point the way to a successful vaccine, the Brisbane, Calif. company said Tuesday.

Although the company's experimental vaccine, AIDSVAX, delivered no protection to most subjects in a clinical trial involving almost 5,000 subjects, the data released in February showed hints of benefit among the 314 black participants. Minority members and AIDS activists have urged the government to make sure no promising leads are abandoned.

Under the new two-year grant, VaxGen will examine the viral strains that infected the study subjects and determine whether an improved vaccine would be more effective against those strains. The company said it is continuing work on the AIDS vaccine -- once its core mission - only to the extent that it receives outside support from the government or philanthropic foundations. "My sense is that the data they have accumulated could be quite valuable in AIDS vaccine research," said Chris Collins of the AIDS Vaccine Advocacy Coalition in New York. "I do think it is appropriate that the government is helping the company to mine that data for the maximum impact."

Back to other CDC news for June 12, 2003

Previous Updates

Adapted from:
San Francisco Chronicle
06.11.03; Bernadette Tansey

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More News and Analysis on Vaccines for HIV Prevention

Tools
 

Advertisement